- Published at
- by thestreet.com
positive
positive
Humanigen To Present At Roth Conference
Humanigen, Inc. (Nasdaq: HGEN)("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called
News for Humanigen Inc (0KB2.F)
- Published at
- by insidermonkey.com
mixedmixed15 Fastest Growing Biotech Companies in the US
In this article we talk about 15 fastest growing biotech companies in the US. You can skip our detailed analysis of the biotech industry and go to 5 Fastest...- Published at
- by marketscreener.com
positivepositiveHumanigen : to Present at Multiple Investor Conferences in March
Humanigen, Inc. , a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate,... | February 25, 2021- Published at
- by benzinga.com
mixedmixedHow The GameStop Pop Compares To Tilray, Volkswagen, Other Historical Short Squeezes
Video game retailer GameStop Corp. (NYSE: GME) is getting a lot of attention so far in 2021 for its dramatic short squeeze that has sent shares soaring from ...- Published at
- by marketwatch.com
mixedmixedHumanigen signs manufacturing deal with Emergent for experimental COVID-19 drug
Shares of Humanigen Inc. undefined were down 2.5% in trading on Monday after it announced a contract development and manufacturing deal with Emergent...- Published at
- by rttnews.com
positivepositiveStock Alert: Humanigen Trading 5% Higher
Shares of clinical stage biopharmaceutical company Humanigen, Inc. (HGEN) are rising more than 5% Friday morning after the company announced expansion of its prevoious deal with the U.- Published at
- by markets.businessinsider.com
neutralneutralHumanigen, EVERSANA Announce Partnership To Support The Launch Of Lenzilumab For COVID-19
(RTTNews) - Humanigen, Inc. (HGEN) and EVERSANA announced partnership to make lenzilumab available to hospitalized COVID-19 patients in the event ...- Published at
- by marketscreener.com
positivepositiveHumanigen : and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19
Humanigen, Inc. , a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate lenzilumab™, and... | January 10, 2021- Published at
- by thestreet.com
positivepositiveHumanigen And EVERSANA Announce Partnership To Support The Launch And Commercialization Of Lenzilumab For The Treatment Of COVID-19
Humanigen, Inc. (HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine